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Abstract 
 
               
        The  present  study  was  carried  out  to  investigate  the toxic effect 
of  potassium  bromate  on  Wistar  albino  rats .  Thirty  rats  were  
divided  into  5 groups  and  treated  with  potassium  bromate  at  doses  
of  0, 50, 100, 200  and  400 mg/kg body  weight respectively  for  21  
days .  The mortality was 100% in rats treated with 400 mg/kg Bwt.  In  
rats  treated  with  100  and  200 mg/kg Bwt a significant  increase  was  
observed in  the  activity of alanine  transaminase (ALT), urea, creatinine  
and  potassium ,and significant  decrease in total protein, albumin and  Na  
level . A significant  decrease  was  also  observed  in  Hb  and  PCV 
values  in the  group treated  with  200 mg/kg Bwt, while  no  significant  
changes  were  observed  in the group  treated  with  50 mg  and 100 
mg/kg Bwt. Histopathological  examination  showed haemorrhage  and  
degenerative changes in  kidney and  liver of  the  group  treated  with 
100, 200 and 400 mg/kg B wt . These  results  suggested that the  toxic  
effect  of  potassium  bromate were  more  sever  at  higher  doses. 
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Introduction 
 
 
    Food  additives  are  substances  added  directly  and  intentionally  to  
food , generally  in  small  quantities , for  improvement  of  specific  
purpose ; however  a non  intentional  additives  may  be  an  integral  
part  of  food .  The  practice  of  adding  chemical  to  food  originated  
thousands  of  years  ago  and  involved   ,  for  example ,  the  use  of  
flavors ,  spices , preservatives  and  repining  agents  (Fennema, 1987).  
Our  ancestors  used  to  preserve  meats  and  fish  with  salt , fruit  with  
sugar  and  cucumber  with  vinegar  solution . With  the  advent of  
processed  food  in  the  second  half  of  the  20th  century , many  more  
additives  have  been  introduced.                                                                                           
     The  additives  play  a vital  role  in  today's  bountiful   and  nutritive  
food  supply  and  are  carefully  regulated  by  various  international  
organization  to  ensure  that  additives introduced into  food  intended  
for  human  consumption  are  safe . However,  toxic  compound  may  be  
formed  through  metabolism  of  non-toxic  additives  either  during  food  
processing  or  after  ingestion . Hence  substances  should  be  considered 
as  additive  if  it  has  no  ill  effects  and  its  margin  of  safety  is  
adequate . 
     Potassium  bromate  has  been  used  as  food  additive  and  was  
listed  as  flour  treatment  agent  by  FAO/WHO  (1964).  Later  on  
deleterious  effects  have  been  realized  and  it  was  claimed  that 
potassium  bromate  is  carcinogenic as well (Chipman et al., 1998 and 
Sai et al. ,1992 ). Several safety  evaluations  have  been  done  and they 
were  controversial. The  final  decision  that  have  been  taken  is  that  
potassium  bromate have  to  be  banned  and  should  not    be  listed  as  
food  additive . 
     In  Sudan ,  however ,  food  adulteration  and  indiscriminate  addition  
of food additives , some  times  toxins , continue  to  be a problem .  
Despite the  precaution  undertaken potassium  bromate  is  still  in  use  
although  it  was  ruled  unsafe . 
      The  present  study  was  aimed  to  evaluate  the toxic effects of  
potassium  bromate  in wistar albino  rats . 
 
Chapter  One 
Literature  Review 
          Food   additives  are  substances  other  than  a basic food  stuff 
which  are  present   in  food  as  a result  of  any  aspects  of  producing , 
processing , storage  or  packaging ( Food   Protection  Committee,1961).         
       The  use  of  food   additives  did  not  engender controversy  until  
the  early  1800s  when  intentional  food adulteration  became  
appallingly  common.  This  problem continued  until  about  1920  when  
regulatory  pressure  and effective  method  of  analysis  reduces  the  
frequency  of  food adulteration ( Fennema  , 1987) . 
       The  use  of  food  additives  have  changed  dramatically during  the  
course  of  history ( Fennema , 1987) . In  1820  the addition  of  a 
chemical  to  food  was  done  for  respectable  reason and  since  early  
1800s  intentional  food  adulteration  increased greatly  in frequency  and  
seriousness .  During  this  period the public  develop  increased  concern  
about  the  quality  of  food ( Accum,  1966) . In  1920  regulatory  
pressure  and  effective method  of  analysis  reduce  the  frequency  and  
seriousness  of  food  adulteration  to  acceptable  level  and  the  safety  
of  the  food supply  has  steadily  improved  since  that  time . In  1950  
new  problem began  when  food  containing  legal  chemical additives 
were prevalent  and  the  use  of processed food  increased and 
contamination  of  some  food  with  the  byproduct  of  industrial  
activity  became  more  common .     
Now  the  uses  of  food  additives  are  more  strictly  regulated  and the  
regulation  required  evidence  that  each  substance  is safe  at  its  
intended  level  before  usage ; also  continuing  governmental 
surveillance of  the  food  supply  with  regulatory  judgments  on  the  
basis  of  emerging  scientific  information  has resulted in  the  
occasional  banning  of  previously  allowed  food additives  or  the  
imposition  of  the  new  restriction  on  its  use ( Fennema   , 1987) .  
Food additives  are  used  for  different  purpose :  as  preservative  used    
to  retard  or  hinder  undesirable  flavor  in  food  and  may  also serve as  
antioxidant  that  prevent  rancidity of  fat  and  oil ( Frazier,    1955) . To  
enhance or maintain  nutritional  values  vitamins  and    minerals  are  
added , to  enhance  color  or  favor , to  improve cooking or  backing  
quality  and  to  bleach  food  like  flour  and    certain  cheese  ( Fraizer,  
1955).   
Potassium  Bromate 
1.1  Physicochemical   Properties 
        Potassium bromate is found as white crystalline odourless powder, 
its molecular formula is KBrO3 with molecular weight of 167.01gm. 
Potassium bromate  decomposes   at  370°C  with density  of  3.27 g/cm  
at  20°C  and  its solubility   in water  is  133 gm/L  at  40°C  and  498 
gm/L at  100°C   (Weast, 1986) . Potassium  bromate  is  strong  oxidizing  
agent  . Biological  bromate  reduction  has occurred  with  bromate  
utilized as terminal  electron  accepter  in  the  absence  of  oxygen  and  
nitrate ( Hijnen et al.,  1995). 
1.2 Metabolism of potassium bromate in animal and  human 
        Following oral administration KBrO3 is rapidly absorbed  from 
gastrointestinal tract. Fujie et al. (1984) administered rats with 100 mg/kg 
Bwt KBrO3 and it was detected in the plasma within 15 minutes. 
Bromate  is  very  stable  in  the  body  and  only  small amount  reduced  
to  bromide  by  glutathione  processes  in  the  liver  and  kidney (Kutom 
et al., 1990).  Potassium  bromate  is  excreted  in  urine  either  as  
bromate  or  bromide  (Fujie  et al.,  1984). 
1.3   Uses  and  action 
       KBro3  is  used  widely  as  a maturating  agent  in  flour  and a 
dough  conditioner  in  the  bakery  industrial (IARC , 1986  and 
Chipman et al.,  1998). KBrO3  was  evaluated  for  flour  treatment  to  
be  at level  of  62.5 mg/kg  flour  (FAO/WHO , 1964) . This is because  
bromide arising  from  flour  treated  with  KBrO3  at  level  less  than  
62.5 mg/kg  did  not  present  toxicological  hazard ; more  over  the  data  
indicated that  no detectable  level  of  KBrO3  were  found  in  bread  
baked  from treated  flour . Potassium  bromate  is  a strong  oxidizing  
agent , its action  in  bread  is  the  formation  of  disulphide  bond  
between  the  wheat  flour  protein  (gluten)  and  strip  the   hydrogen  
atom  from  the  sulfhydral   linkage  so  make  more  sulphur  available  
for  the  gluten strengthened disulphide  bond ;  hence  strengthened  the  
dough  and more elastic  gluten  network  was  produced  which  is  
capable  of expanding  and  increasing  gas  retaining  capacity. This has 
economic advantage  by  shortening  make  up  time or  compensation for 
low  protein  level  in  flour  (www.foodproductdesign.com  1999 ) .  The 
accepted equation for KBrO3 reaction as proposed by Tkachuk and 
Hlynka (1961) is: 
  BrOֿ3     +         6RSH          →       Br -  +       3RSSR            +   3H2O 
(Bromate)       ( ProteinThiol)                         (Protein Disulfide)  
      Potassium bromate  is  also  used  for  improvement  of  fish  paste , 
as  oxidizing  agent in  manufacture  of  certain  cheese and  in  treating  
barely  in  beer  making  (IARC  1986  and  Chipman et al.,  1998) . 
      Potassium  bromate is a constituent  of  cold  wave  hair  formulation. 
The  formulation  kits  consist  of ammonium  thioglycolate  solution  
that  reduces  the  keratin  disulfide  bond  to  make  the  hair  flexible  
and  neutralizing solution which  contain potassium  bromate  or  iodate  
as an  oxidizing  agent  that  convert  the  sulfhydral  group back to  
disulphide bond which  stabilize  the  new  form  of  the  hair  (DeVriese  
et al.,  1997) . It  is  also  used  as  a primary  standard  and  brominating  
agent  in  analytical  chemistry  and  in  the production  of  explosive  
(DeVries  et al.,  1997) .  
      Potassium bromate  is  generated  as  a contaminant in  drinking  
water  due to conversion of bromide  found  naturally  in  water to  
bromate  by  ozone  when  the ozone  is  used  to  disinfect  water . It  is  
frequently  detected  in  tap  and  bottled  water  ( Ueno  et  al.,  2000) .It  
is currently  regulated  in  treated  drinking  water  at  a maximum  
contaminant  level  of  10µg/l   in   USA  and  Europe  (U.S. EPA  2001) .  
1.4  Toxicity  and  Safety 
        Potassium  bromate  is a highly  reactive  substance  which  breaks 
down  to  the  inactive  bromide  during dough fermentation  and  baking.  
It was considered that this break down was complete  
(www.archive.food.gov 1993). However,  analytical  techniques  are  
now  available  to detect  bromate  up to a level  of  few  part  per  billion  
(PPb) (IARC  1986) . JECFA  (1989)  recommended  that  there  should  
be  no  residue  of  KBrO3  in  food  when  it  is  used  in  food   
processing  to  avoid  its  toxicity .  
    Toxicity  of  potassium bromate  have  been  reported  in  experimental  
animals . Mark  (1988)  reported  that  the  lethal  oral  doses  of  KBrO3  
in  human  estimated  to be  154-385 mg/kg  body  weight , while  serious  
poisoning  result  at doses  of  46-92 mg/kg Bwt .He  also  stated  that 
oral  doses  of  185-385mg/kg  result  in  irreversible  toxic  effect  
mainly renal  failure  and  deafness  in  human  and  lower  doses 
associated  with  vomiting , diarrhea , nausea  and  abdominal  pain . 
Watanabe et al. (2004)  studied  acute  exposure  of  mice  to   KBrO3  
administered  orally  at  a rate  of  1.2 mmol/kg  body  weight  and  
sacrificed  3 hours  after administration . He  found  significant  elevation  
of  serum  uric  acid, serum  creatinine  level, xanthine  oxidase   activity,  
relative  kidney weight  and  renal oxidative  stress  which  is  an  
indicator  of kidney damage .  
      In another  study  Okolie  and  Ikewuchi  ,(2004)  indicated  that 
KBrO3  induced  oxidative stress  on  some  cataractogenic   indices  in 
lens, cornea  and  retina  of  white  rabbits  receiving  60 mg/kg  body  
weight  orally  for  28 days . They  also  stated  a significant  decreases  
in  the  activities  of  Na , K  ATPase,  catalase , superoxide  dismutase  
and  anti-oxidant  vitamins A and C .Several  reactive oxygen  species 
(ROS)  generated  from KBrO3  (  peroxy nitrite ONOO¯ , hydrogen  
peroxide  H2O2 , super oxide  anion  O¯2  and  hydroxyl  radical  OH¯ ) 
that  might  be a principle  agent  for  KBrO3  provoked  oxidative  stress  
( Okalie  and  Ikewuchi , 2004)  . Potassium  bromate  brings  about  
serious  oxidative  modification  to  protein,  lipid  and  DNA (Chipman 
et al.,  1998  and  Watanabe et al., 2001)  . 
     In  another  study  performed  by  Khan  et al. (2003)  in  rats  treated  
with  125 mg/kg  Bwt KBrO3 intrapretoneally  the  results  showed  
marked  increase  in  the  level  of  blood  urea  nitrogen  (BUN) , serum  
creatinine , reduction  of  anti-oxidant  enzymes, enhanced  xanthine  
oxidase  and  lipid  peroxidation . 
El-sokarry  (2000)  reported  the  protective effect of melatonin  for  the  
kidney  and  liver  of  rats  treated  with  100 mg/kg  Bwt KBrO3 for 24 
hours , significant  increased  in  malondialdehyde  (MDA)  was observed  
as  an  indicator  of  lipid  peroxidation . Histopathological  examination  
revealed  a typical  tubules ,a typical  hyperplasia , hyaline  droplets  
degeneration  and  necrotic  changes .  
      Farombi et al. (2002)  examined  the  effect of  kolaviron  in 
oxidative  stress  in  kidney  and  liver  of  rats  treated  with KBrO3  
intragastrically  as  a single  dose  of  300 mg/kg B wt .  The  result  
showed significant  increase  in  relative  kidney  weight  while  the  body  
weight  and  relative  liver  weight  did  not  affected ,decreased  in  
superoxide  dismutase , glutathione  peroxidase  and  catalase  in  kidney  
were  also  reported .  
         Kurokawa  et al. (1990)  reported  that  when rats  received  KBrO3  
for  13  weeks  at  rates  of  150 , 300 ,  600 , 1250 , 2500 and  5000 mg /l  
of  drinking  water , all  animals given  doses  greater  than  1250 mg/l 
died  within 7 weeks. However, significant increase in alanine 
transaminase (ALT) aspartate  transaminase (AST), blood urea nitrogen 
(BUN) were  reported  in   rats  dosed  with  600  mg/kg Bwt. 
      The  carcinogenic  and  mutagenic  effects  of  KBrO3  have  been 
also reported  in  experimental  animals  (Ishidate et al., 1984 and  
Kurokawa et al., 1987) . It was classified as group  2B   possible  human  
carcinogen  by IARC (1986) . DeAngelo  et al. (1998)  studied  the 
carcinogenicity  of  KBrO3  in   mice  and  rats . Mice  were  treated  with  
0.08 , 0.4 and 0.8 g/l    in  the  drinking  water  for  100 weeks  and  rats  
were treated with  0.02, 0.1,0.2  and  0.4 g/l  for 100 weeks . The  results  
showed  that  KBrO3  is  carcinogenic  to  the  rats  kidney  , thyroid  and  
mesothelium  and  is  renal  carcinogen  to  mice .  
          Another  study  by  Umemura  et al. ( 1993)  about carcinogenicity  
in  rats  exposed  to  KBrO3  in  drinking  water revealed  an  increased   
cell proliferation   in  the  proximal  tubules .  The genotoxic  potential   
of  KBrO3  was  also tested  in  Chinese  hamster  cell (Speit  et al.,  
1999). Detection  of  oxidative  DNA  damage  were  observed . 
Molecular analysis  of  deletion  mutation  indicated  a high portion  of  G 
to T transversion  which  arises  after  replication  of  8-
oxodeoxyguanosine generated  from  deoxyguanosine  upon oxidation   
by  KBrO3 . 
      Chipman et al. (1998)  have  examined  the  DNA  damage with  
KBrO3  following  incubation  of  calf  thymus  DNA with  KBrO3, the  
result showed significant increase in concentration of 8-
oxodeoxyguanosine  relative to  deoxyguanosine . The  role  of  oxidative  
stress  in  carcinogenesis    were  also  shown  in  study  conducted  by  
Umemura  et al. (1995) . 8-oxodeoxyguanosine  level  were  measured  in  
the  kidney  and  liver  of  rats  received doses  of 100,  200  and  400 
mg/kg Bwt  in  the  drinking  water  for  30 weeks . 8-oxodeoxyguanoine  
levels  in  kidney  were  significantly  elevated  with  doses  of  200 and 
400 mg/kg Bwt . No  significant  changes  were  found  in  liver . Number  
of  a typical  tubules,  a typical  hyperplasia  and  renal  cell  tumor  were  
significantly  higher .    
1.5  Detection  of  potassium  bromate  
      Himata et al. (2000)  showed  that  KBrO3  in  bread and  baked  
good  as  low  as 5 ppb  (ng/g)  can  be  detected  using liquid 
chromatography . In another  study   Dennis et al. (1994)  detected 
KBrO3  to a limit  of 12µg/kg bread using  gas chromatography .  
 
 
 
 
 
 
 
Chapter two 
 
Materials and Methods 
 
 
2.1  Materials and Experimental Design 
 
 
2.1.1  Potassium Bromate (KBrO3) 
 
       Potassium Bromate in a powder form was supplied by Sudanese  
Consumer Protection Association at Khartoum. 
2.1.2  Animals 
   Thirty healthy wistar albino rats of both sex weighing from (60-70gm) 
were supplied by Medicinal and Aromatic Plant Research Institute 
MAPRI),National Research Center. They were housed under standard   
conditions within the premises of (MAPRI) and have free access to water 
and standard diet. They were left for a week as an adaptation period 
2.1.3 Experimental Design                                                                 
      At the end of the adaptation period the rats were divided randomly 
into five groups (6 in each).    Group I was left as control, while groups 
II, III, IV and V were orally  administered with KBrO3 using nasogastric 
tube ( HFR [8] K AMOTO CORPORATION OSAKA JAPAN) daily at    
 concentration rate of 50, 100, 200 and 400 mg/kg body weight  
respectively for  21  days .                                                                         
2.1.4 Parameters                                                                                    
Clinical signs and mortality were recorded. Body weights were    recorded 
regularly every week. Blood samples were obtained for   haematological 
investigation which included red blood cells (RBCs) count, white  blood  
cells  (WBCs) count , packed cell volume (PCV),   haemoglobin 
concentration (Hb) ,mean corpuscular haemoglobin concentration (MCHC) 
and mean corpuscular volume (MCV) .                            
 Serum investigation included , total serum protein concentration, albumin 
concentration  , globulin  concentration , alanine transferase (ALT) activity 
, urea, creatinine , sodium  and  potassium  concentrations .         Organ 
weights,  namely, liver , kidney , heart , lung and  spleen  were  taken after 
death or  slaughter. Slices  from liver , kidney , stomach , heart, lung , 
spleen and  brain  were collected after  death  or slaughter and  fixed in 
10%  neutral buffered  formalin  for  histopathological investigation .  
2.2  Methods 
 
2.2.1 Haematological Methods 
 
    Blood samples  were  collected  by  puncturing  retro- orbital  plexus , 
with  heparinized   capillary  tube  (SUPE-PIRO-GERMAN  code  N-4361),  
into dry clean  tube  containing  ethylenediaminetetraaceticacid  (EDTA)  as 
an anticoagulant. The haematological procedure was done  according to 
(Schalm, 1965). 
2.2.1.1 Red Blood Cells (RBCs) Count 
       RBCs were counted  using  improved  Neubaur haemocytometer 
(Hawksly  and  son  Ltd  , England) . Hayem's Solution  was  used as a 
diluent (Sodium  chloride  1.0gm , sodium   sulphate   0.5gm ,mercuric  
chloride 0.5gm  and  made  up  to  200ml  with distilled water ).  RBCs  
were  expressed  in  millions/mm3  blood 
2.2.1.2 White Blood   Cells (WBCs) Count 
 
    WBCs  were  Counted  using  improved  Neubaur  hemocytometer  
 (Hawksly and   son  Ltd , England).  Turk's  Solution  was  used  as   
diluent .WBCs were expressed  in  thousand/mm3  blood . 
2.2.1.3 Packed Cell Volume (PCV) 
    PCV was measured using hematocrit method .Bloods sample were 
placed in the  capillary  haematocrit  tube  and   centrifuged    using  
haematocrit centrifuge  (Hawksly  and  son  Ltd , England) .The  PCV  
percent was  read  on the  scaling  instrument  provided with 
microhaematocrit .  
1.1.2.4 Haemoglobin (Hb)   concentration 
       The determination of Hb concentration was  based on the  conversion   
of Hb to  cyanomethaemoglobin  by  mean's  of  Drabkin's  solution 
(Potassium cyanide 0.2gm , potassium  ferricyanide  0.2gm  and  sodium 
bicarbonate 1.0gm  in a liter of distilled  water) .The  coloured  solution  
was read  with  spectrophotometer( JENWAY 6305 UV/Vis) at  wave  
length 540 nm and  compared against standard Hb(cromatest ).Hemoglobin 
concentration was  expressed as follow :  
 
Hb (g/dl) =    tested sample×15 
                     Standard sample 
Where 15 was the standard concentration.  
2.2.1.5 Mean Corpuscular Hemoglobin Concentration  
  (MCHC) 
    MCHC percentage was   calculated from Hb and PCV values as follows: 
MCHC (%)    =  Hb (g/dl) ×100   
                            PCV% 
2.2.1.6 Mean Corpuscular Volume (MCV) 
      MCV in cubic microns was caculated from RBC and PCV values as          
follows: 
 MCV (cubic microns) =       PCV percent    ×10 
                                           RBCs count (million/cmm) 
                                                                
2.2.2 Chemical Methods 
       Blood  samples  were  taken  in a similar  procedure  as  haematology 
into dry clean  tubes  and  allowed to  clot  at  room  temperature for  30 
minutes  then centrifuged (Hittich  EBA35) at  3000 r.p.m . Sera  were 
separated  and  stored  at – 20°C  until  analyzed  for biochemical 
investigation. 
2.2.2.1. Total protein determination  
        The  determination  of  total  protein  concentration  was  done 
according  to  Biuret  method described  by  Reinhold  (1953) . 
Principle of the method:- 
The  principle  of  this  method  is  based  on  the  reaction  of  protein   
peptide  bond  with  cupric  ion  in  alkaline  media  found  in  Biuret   
solution   (sodium  potassium tartarate  9.0gm  Cuppric  sulphate  3.0 gm,  
potassium  iodide  5.0 gm ,  sodium  hydroxide  2N and  made  up  to one  
liter distilled water)  and  resulting  in  formation  of coloured  complex. 
Protein + cuppric  ion  →  protein  cupric  ion  complex 
Procedure: 
The prepared sera and reagent were placed in water path at 37°C. Changes 
in scaling  reading  of  spectrophotometer  (JENWAY  6305 UV/VIS) at 
wave  length  540 nm were  recorded.  The  concentration  of total   
protein was  calculated  as  follow : 
         Total protein (g/dl) =    tested sample ×6    
                                     Standard sample  
Where 6 was the concentration of the standard.   
2.2.2.2. Albumin  determination 
     Albumin  concentration  was  measured  using  Bromo Cresole Green 
(BCG) method  described by Spencer  and Prince (1977).  
Principle of the method: 
The  principle  of  this  method  is  based  on  quantitative  binding    of   
serum albumin  to  BCG. 
Procedure: 
The  prepared  sera  and  reagent  were  mixed and  incubated  at  37°C   
and  were  read  at  wave  length  of  670 nm  using  spectrophotometer.  
Albumin  concentration  was  calculated  as  follow: 
Albumin (g/dl) = tested sample×5  
 Standard sample 
Where 5 was the concentration of the standard.  
2.2.2.3 Globulin  determination 
      This  parameter  is  obtained  by  subtracting  Albumin  concentration   
from  total  protein   concentration. 
2.2.2.4 Alanine  Transaminase (ALT) 
          This enzyme is formerly known as Glutamate Pyruvate 
Transaminase  (GPT).  The  determination of  serum  ALT  activity  was 
done according  to the  method  of  Reitman  and  Franklin (1957). ALT 
catalyzes  the  transfer  of the  amino group  of  glutamate to  pyruvate  in   
a reversible reaction: 
 Oxaloacetate + alanine  →  glutamate + pyruvate 
      ALT  is  measured  by  monitoring  the  concentration  of  pyruvate 
hydrozone formed  by  reaction  with  2-4-dinitrophenyl hydrazine 
(DNPH) in alkaline  solution . ALT  substrate  was  incubated  for  5 
minutes  at 37°C  then  the  sera  were added,  mixed  and  left at 37°C for 
30 minutes ,  then  a colour  reagent  were  added and  mixed at  room 
temperature for 20 minutes. The optical density was measured at 505nm 
with spectrophotometer.  
ALT values was expressed   in U/L 
2.2.2.5. Urea determination  
                                                                                             
          Urea concentration in sera was measured using enzymatic 
colorimetric  method  described  by  Monica  (1992) . 
Principle of the method: 
The  principle  of  this  method is  that  urea is hydrolyzed by urease  to 
ammonia  and  carbon  dioxide . The  intensity  of  the color formed  
when ammonia  reacts  with  alkaline  hypochlorite  and  sodium  
salicylate  is proportional to the  concentration of urea in sera  samples. 
 Urea + H2O   →  2 NH3 + CO2                                                                                                          
Procedure: 
  The prepared sera and reagent were placed at room temperature. The  
colour  intensity  was  measured  using  spectrophotometer at wave  
length  600 nm  and  urea  concentration  was  calculated  as follow :        
Urea  (mg/dl)  =  tested sample ×50    
                            Standard sample  
Where 50 was the standard concentration.  
                                                    
2.2.2.6. Creatinine determination 
                                                                                                                              
     Concentration  of  serum  creatinine  was  measured  by  an  enzymatic   
colorimetric  method (Monica ,  1992) . This  procedure  is based on 
picrate reaction  method . 
Principle of the method: 
The  principle  is that  creatinine  in  alkaline  solution  react  with  picrate 
ion  forming  a redish coloured  complex . The  amount  of  the  colour 
formed  is  directly proportional  to  the  creatinine  concentration  in sera  
samples .  
 Creatinine + picric  acid  → red  colour  complex   
Procedure: 
  The  prepared  sera and reagent were  mixed and placed at  37°C.   The  
absorbance (A) of  the  sample  and  standard  were  read  at  510 nm   
after  30  seconds (A1) , and  after  90 second later (A2) , and  creatinine  
concentration  was calculated  as  follow : 
Creatinine  (mg/dl)  =  A sample ×2      
                                     A standard 
Where 2 was the standard  concentration.  
A  = A2-A1 
2.2.2.7 Sodium determination   
    Serum  sodium  concentration  was  determined  using  flame 
Photometer  (Varley,  1967  and  1980). 
Principle of the method: 
The  principle  of  this  method  is  that ; the  flame  emission  photometer  
is used  to measure  the  light  emitted  by  exited  atoms  (alkali  metals  
Na ,K and  Li  are  easy  to  excite) .The  solution  of  sodium is aspirated  
into  the  flame . Firstly the flame breaks  the  molecular bonds  and  
converts  it to  the  atomic  state . As  the  temperature  rises the  atoms   
absorb  energy  and  enter the  exited  electronic  state . The exited  atom   
return  to  the  ground state  by  emitting  light  of characteristic  wave   
length . The emission  flame  photometer  (corning flame  photometer-
400)  was used  with  wave  length  590 nm .  
Procedure: 
0.1ml  of  sera  was diluted  with  9.9 ml  distilled  water,  the  diluted   
sample  was  read  against  the  low  standard  of  sodium . Sodium   
concentration  was  calculated  as  follow : 
Sodium  (mEqu/L)   = reading  of  test ×140    
                                  reading  of  standard    
 
Where 140 was the standard  concentration  
2.2.2.8.  Potassium determination 
      Serum  potassium  concentration  was  measured  using  flame 
photometer  according  to  (Varley,  1967  and  1980). 
Principle of the method: 
The  principle  is  similar  to  that  of  sodium  except  using solution  of  
potassium  and  wave  length  of  770 nm  . 
Procedure: 
0.1ml of  serum  was  diluted  with  9.9 ml  distilled  water  and the 
diluted  sample  was  read  against  the  low  standard  of potassium. 
Potassium  concentration  was  calculated  as  follow: 
Potassium ( mEqu/L )  =  reading  of  test ×5     
                                         reading of standard   
 
Where 5 was the standard  concentration 
  
 
2.2.3. Histopathological  Methods 
       Slices  from  organs  liver,  kidney,  heart, lung, spleen, stomach,  
intestine and brain  were  collected  from  dead or slaughtered   rats  and  
fixed  in  10%  neutral  buffered formalin (sodium  hydrogen  6.5 gm/L  
and   sodium dihydrogen 4.0gm/L) ) then  embedded  in  paraffin  wax  
and sectioned  at  5 µm  and  stained by  Hemotoxyline  and Eosin (H&E) 
using  Drury  and  Wallington  (1980)  method.  
2.2.4 Statistical  Analysis 
       Data  were  analyzed  statistically  by  student  t-test  (Mendehall,  
1971).   
 
Chapter three 
 
Results 
 
 
3.1 Clinical Signs and Mortality 
 
 Rats received  50 mg/kg B wt  showed no clinical signs,  whereas  
depression and difficulty  in breathing  were  observed   in  rats which  
received  100 and  200 mg/kg Bwt.  The  mortality  was  100%  in  rats 
which  received  400 mg/kg Bwt  after  the  third  day  of  dosing. 
 
3.2 Body Weight and Relative Organs Weights 
 
Table (1) shows the effect of various doses of potassium bromate 
on rats body weights. No significant differences were  observed between 
control rats and treated ones throughout experimental period in the body 
weight. There  were no significant differences  in  the  relative  weights  
between  control  rats  and  those treated  with  50 mg/ kg Bwt, while  
significant (P<0.05) increases  were  observed  in  the  relative  weight  of  
liver  and  kidney  in  those  received  100  and  200 mg/kg Bwt (Table 2). 
 
3.3 Haematological   Findings 
 
      The haematological findings in rats treated with potassium bromate 
are summarized in table (3).  There  were  no  significant  differences in   
      
 
 
 
Table [1]: The mean body weights (gm) of rats orally treated                                          
 with various levels of potassium bromate 
 
Doses mg/kg Bwt Week1 Week2 Week3 
0 
 
50 
 
100 
 
200 
 
69.5±7.2 
 
67.0±3.1 
 
68.8±3.1 
 
66.6±5.0 
79.0±8.3 
 
76.0±6.1 
 
77.3±4.6 
 
71.7±3.7 
86.5±9.4 
 
83.0±6.1 
 
79.1±5.6 
 
74.0±4.2 
 
 
 
 
 
Table [2]: The mean relative organ weight (%) of rats orally             
 treated with various levels of potassium bromate 
 
                        Relative organ weight (%) Doses 
mg/kg Bwt Kidney Liver Heart Lung Spleen 
0 0.72±0.08 
 
3.0±0.09 0.46±0.03 0.75±0.06 0.3±0.05 
50 0.82±0.07 
 
3.3±0.05 0.40±0.01 0.73±0.07 0.28±0.08 
100 0.99±0.02* 3.8±0.04* 0.43±0.08 0.80±0.04 0.25±0.09 
 
200 1.20±0.09* 4.4±0.10* 0.38±0.02 
 
0.79±0.02 0.27±0.02 
 
* P<0.05 
 
 
 
 
 
 
RBCs  and  WBCs,  count  Hb  concentration  and  PCV  value between 
control rats and those dosed  with 50 and 100 mg/kg B wt . However,  
 there  was a significant  decrease  in  Hb  concentration  and  PCV  
values  in  group  treated  with  200 mg/ kg B wt KBrO3 after  the  second  
week  ( P< 0 .05) .  Also there  were  no  significant  differences  in  
MCHC  concentration  and  MCV   in  groups  treated  with 50 and 100 
mg/kg Bwt potassium  bromate  , but  in the group  treated  with  200 
mg/kg Bwt a significant  decrease  was  observed   in  MCHC  
concentration  after  the  second  week  ( P <0.05 ).  
3.4 Changes  in  Serum  Constituents 
The  effects  of  various  doses  of  potassium  bromate  on  
concentrations  of  total  protein  , albumin , globulin , albumin : globulin  
ratio  and  activity  of  alanine  transaminase  are  given  in  table (4) .    
There  were  no  significant  differences  between  control  rats  and    
the group treated  with  50 mg/kg Bwt  in  total  protein  and  albumin  
concentrations.  However,  in the group  treated  with  100 mg/kg Bwt  
significant  decrease  was  observed  after  the  second  and  third  weeks  
( P < 0.05 ) , in the group  treated  with  200 mg/kg Bwt a significant  
decreases  were observed in  total  protein  concentration  at  the  second   
week and  in  albumin concentration  through out  experimental  
period  (P < 0.05 ) . 
 
Table [3]: The mean haematological changes of rats orally treated  
 with various levels of potassium bromate 
 
Duration Doses RBCs WBCs Hb PCV MCHC MCV 
(week) mg/kg
B wt 
×106/ mm3  ×103/ mm3 g/dl % % fl 
0  4.9±0.25 
 
6.3±0.85 13.0±0.72 33.7±0.96 38.6±0.80 69.0±0.3 
50 4.9±0.69 
 
6.9±1.10 12.9±0.33 33.8±1.60 37.8±0.25 68.0±0.6 
100 4.8±0.60 
 
6.6±1.00 11.9±0.97 31.5±2.70 37.7±0.56 66.0±1.3 1 
200 5.3±0.58 
 
7.2±1.40 11.5±1.00 34.0±1.80 33.8±0.19 64.0±1.8 
0 5.1±0.28 
 
6.2±0.28 13.4±0.70 35.8±0.96 37.4±0.65 70.0±1.8 
50 4.9±0.40 
 
5.6±0.44 13.2±0.66 36.2±1.20 36.4±0.30 74.0±1.2 
100 4.8±0.48 
 
5.9±0.09 13.8±0.24 35.6±1.80 38.7±1.10 74.0±0.5 2 
200 4.3±0.36 
 
5.6±0.51 10.4±0.50* 29.3±0.2* 35.4±2.50* 68.0±1.1 
0 5.3±0.82 
 
6.7±0.36 13.3±0.53 34.3±1.50 38.7±0.40 65.0±0.8 
50 5.2±0.66 
 
6.2±0.47 12.7±0.85 32.8±1.50 39.6±0.50 63.0±1.2 3 
100 4.3±0.48 
 
6.2±0.54 11.3±1.40 30.3±2.50 37.2±1.50 70.0 3.1 
 
* P<0.05 
 
 
 
 
 
 
 
There  was  no  significant  differences  in  globulin  concentration  
between  control  and  treated  groups . While   significant  decreases  
were  observed  in  albumin : globulin  ratio  in  those  treated  with 100 
mg/kg B wt at  the  third  week  and  the group  treated  with  200 mg/kg 
Bwt throughout  experimental  period  ( P<  0.05 ).  There  was  no  
significant  changes  in  ALT activity  in the group  treated  with  50 
mg/kg B wt , but  significant  increases  were observed  in the groups 
treated  with  100 and 200 mg/kg B wt   throughout the experimental  
period  ( P<0.05 ) .   
      The effects of various doses of potassium bromate on concentrations 
of urea  , creatinine  , sodium  and  potassium are given in  table (5). 
     There were no significant differences in the concentration of urea 
Creatinine, Na , and  K levels   between  control and  rats  received  50 
mg/kg B wt .  However,  significant   increases were observed   in urea 
and creatinine  levels  in the groups  treated  with  100 and  200 mg/kg B 
wt  throughout the experimental  period  (P < 0.05 ) . Meanwhile 
significant decreases in  sodium  levels   were observed  in the group  
treated  with  100 mg/kg B wt  after  the  second  and  third  week  and the  
group  treated  with  200 mg/kg B wt  throughout  the  experimental  
period  ( P < 0.05 ) . Significant  increases   were  observed  in  potassium  
levels  after  the  second   and  third  week  in the group  treated  with  
 
100 mg/kg Bwt but throughout  experimental   period  in the group  
treated  with  200 mg/kg B wt  . 
3.4 Histopathological  Finding 
 
      In the group  treated  with  400 mg/kg B wt  the  kidney  showed  
haemorrhage , proteinaceous  material  in  the  lumen  of  the  tubules  
beside  tubular  degeneration fig (1). The  liver  was  congested  and  
haemorrhagic fig(2). There  were haemorrhage  and  degeneration  in  the  
stomach fig(3), haemorrhage  in  the heart  and depletion  of  lymphocyte  
in the spleen .  
      In the group  treated  with  200 mg/kg Bwt the  kidney  is  
haemorrhagic  and  congested. congestion of the liver, Haemorrhage  and  
area  of  degeneration  in  the  heart, fig (4) . The  intestine  showed  an  
increase  of  goblets cell fig (5). Sloughing  and  necrosis  of  the  
epithelium  were  evident  in the stomach . The  spleen  showed  depletion  
of  lymphocyte (fig 6). Congestion  and  vaculation  were  seen  in the 
brain fig (7).    
      In  the group treated  with  100 mg/kg B wt the  kidney  was  
haemorrhagic and congested.The liver showed congestion and 
vaculation.The lung was haemorrhagic, congested and pneumonic fig (8), 
also sloughing  of epithelium  of  stomach  was  evident fig (9) . 
There were no  pathological   changes    seen in the group  treated  with  
50 mg/kg Bwt 
 
Table [4]:The mean  changes  in  serum  constituents of  rats orally             
  treated with various levels of potassium bromate 
 
Duration 
(week) 
Doses 
mg/kg 
B wt 
Total 
protein   
g/dl 
Albumin 
g/dl 
Globulin 
g/dl 
Alb/Glb 
ratio 
ALT 
U/l 
 
1 
 
 
0 
 
50 
 
100 
 
200 
 
6.6±0.53 
 
6.8±0.46 
 
6.2±0.40 
 
6.0±0.43 
3.8±0.67 
 
3.6±0.46 
 
3.1±0.48 
 
2.9±0.22* 
2.9±1.10 
 
3.3±0.79 
 
3.0±0.86 
 
3.0±0.16
1.3±0.90 
 
1.09±0.63 
 
1.03±0.70 
 
0.97±0.20* 
 
23.7±5.30 
 
26.6±0.50 
 
32.2±3.70* 
 
42.3±0.43* 
 
 
 
2 
0 
 
50 
 
100 
 
200 
 
7.8±0.68 
 
7.0±0.69 
 
6.0±0.49* 
 
5.3±0.53* 
3.7±0.55 
 
3.1±0.65 
 
2.7±0.37* 
 
2.3±0.15*  
4.2±1.20 
 
3.9±0.50 
 
3.5±0.53 
 
3.1±0.37
0.88±0.90 
 
0.79±0.60 
 
0.77±0.45 
 
0.74±0.30* 
28.5±4.7 
 
30.2±4.5 
 
44.5±.20* 
 
56.3±3.2* 
 
 
 
3 
0 
 
50 
 
100 
 
7.3±0.96 
 
6.3±0.45 
 
5.8±0.54* 
 
 
3.7±0.50 
 
3.0±0.14 
 
2.5±0.42* 
3.6 ±.10 
 
3.3±0.46 
 
3.0±0.61
1.03±0.80 
 
0.91±0.30 
 
0.83±0.52* 
31.0±3.9 
 
37.4±4.6 
 
57.0±6.5* 
 
* P<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table [5]: The mean changes in serum constituents of rats orally    
   treated with various levels of potassium bromate 
 
Duration 
(weeks) 
Doses 
mg/kg B wt 
Urea 
mg/dl 
Creatinine 
mg/dl 
Sodium 
mEq/L 
Potassium 
mEq/L 
1 
0 
 
50 
 
100 
 
200 
 
26.7±5.4 
 
28.6±4.2 
 
33.4±2.8* 
 
41.7±5.0* 
1.0±0.40 
 
1.2±0.50 
 
2.4±0.48* 
 
3.0±0.82* 
137.5±3.8 
 
134.8±2.9 
 
130.0±4.6 
 
123.0±3.5* 
3.5±0.40 
 
3.6±0.12 
 
3.9±0.50 
 
5.2±0.40* 
2 
0 
 
50 
 
100 
 
200 
 
35.5±9.0 
 
34.0±4.7 
 
49.0±1.0* 
 
57.0±2.9* 
1.2±0.3 
 
1.4±0.25 
 
2.8±0.96* 
 
4.8±0.40* 
136.0±3.3 
 
136.0±7.5 
 
127.2±5.2* 
 
117.3±4.3* 
3.4±0.45 
 
3.9±0.50 
 
4.4±0.30* 
 
6.3±0.35* 
3 
0 
 
50 
 
100 
 
 
31.5±6.5 
 
39.3±4.5 
 
50.0±5.0* 
 
 
1.6±0.4 
 
1.8±0.27 
 
3.9±0.63* 
 
 
134.0±5.9 
 
139.0±2.5 
 
123.8±3.3* 
 
  
3.3±0.38 
 
3.8±0.50 
 
5.7±0.50* 
 
 
 
* P<0.05 
 
 
 
 
   
 
 
 
 
Fig (1) Kidny from rats received 400 mg/kg B wt of KBrO3 .Note, tubular 
degeneration  and  congestion.  H&E x10.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (2) Liver from rats recieved 400 mg/kg B wt of KBrO3. Note, 
congestion,  haemorrhage and fatty changes. H&E x20.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (3) Stomach from rats recieved 400 mg/kg Bwt of KBrO3. Note, 
degenration  of the mucosa. H&E x20. 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (4) Heart from rats received 200 mg/kg B wt of KBrO3. Note, 
haemorrhage and degeneration of cardiac muscles. H&E  x20.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (5) Intestine from rats received 200 mg/kgB wt of KBrO3. Notice 
increased goblet cells. H&E x20.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Fig (6) Spleen from rats received 200 mg/kg B wt of KBrO3. Notice 
lymphocyte depletion. H&E x20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (7) Brain from rats received 200 mg/kg B wt of KBrO3. Note, 
congestion and vaculation . H&E x10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (8) Lung from rats received 100 mg/kgB wt of KBrO3. Note,  
congestion  and atelactasis. H&E x20.  
 
 
  
 
Fig (9) Stomach from rats received 100 mg/kg B wt of KBrO3. Note,  
sloughing of the epithelial mucosa. H&E x20.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four 
                             Discussion 
       The  present  study  has  shown    that  more  rapid  death  occurred 
when  potassium  bromate  has  been  given  at the rate  of  400 mg/kg  
B wt.This  pointed out  the  correlation  of  potassium  bromate  effects  
with the dose.This finding is similar to that reported by Kurokawa et al.  
(1990)  who  found the  lethal  dose of  potassium  bromate  in  rats  
range  between  280-495 mg/kg B wt. 
       When  potassium  bromate  given  to  rats  at  a dose  of  50 mg/kg 
B wt there were  no  signs  of  toxicity  as  indicated  by  the  non  
significant alteration in haematology, serum constituents or 
histopathology. 
       However,  doses  of  100,  200 mg/kg Bwt  potassium  bromate  
exhibited  signs  of  poisoning  which  was  illustrated  by  depression  
and  difficulty  in  breathing.  The  generalized  congestion  and  
pneumonia  correlate  the  appearance  of  clinical  signs. 
       There  were  no  significant  effects  on the body  weights  in rats    
dosed  with  potassium  bromate.  This  indicates  that potassium  
bromate  has  no  effect  on  the  growth  rate.  This  is correlated  to 
Farombi et al. (2000) and Watanabe et al. ( 2004)  who reported that no  
effect  on the  body  weight,  but  in contrast  to  Okolie  and  Ikewuchi  
(2004) who reported a significant  decrease  in the body  weight. 
The  relative  kidney  and  liver  weights  were  increased  in rats  
received  100  and  200 mg/kg  potassium  bromate.  This  finding  is  in  
line  with  the  results  obtained  by Farombi  et al. (2000)  and   
Watanabe  et al.  (2004) .  
       The  transient  decrease  in  Hb  and  PCV  values  in  rats  received  
200 mg/kg B wt  potassium  bromate  at  the  second  week  is  an  
indicator  of  anemia.  Similar  results  were  reported  by    Chipman  et 
al.  (1998)  and  Watanabe  et al.  (2001)  who  claimed  that  potassium  
bromate  was  known  to  induce  methaemoglobinaemia  and  cyanosis  
that  resulted  from  oxidation  of  ferrous  ion  to  ferric  by  reactive  
oxygen  species  (ROS)  generated  from  potassium  bromate. 
    The  increase  in  serum  creatinine and  urea  levels  are  indication 
of  renal  toxicity.  This  is  illustrated  by  the  pathological  changes  
seen  in  the  kidney.  This  is  in  harmony  with  Khan et al.  (2003)  
and Watanabe  et al.  (2004) .   The  decrease  of  sodium  beside  the  
increase  of  potassium  levels  may be reflected  by  the  toxic  effects  
of  potassium  bromate  on  the  kidney  as  sodium  and  potassium  
levels  are  regulated  by  the  kidney.  The  effects  are  either  on  the  
permeability  of  the  tubular  cell  membrane  or  on  the  tubular  
epithelium  where  minerals  are  reabsorbed.  Sodium  and  potassium  
are  also  regulated  by  Na-K ATPase,  the  activity  of  this  enzyme  is  
reported  to  decrease  by  the  oxidative  effect  generated  by  (ROS)  
(Okolie  and  Ikewuchi,  2004). 
     The  reduction  of  total  protein  and  albumin  may  be  due  to  liver  
damage  which  resulted  in  reduction  of  protein  synthesis.  The  
increase  of  ALT  may  be  attributed  to  the  high  permeability  of  the  
hepatocyte  membranes  or  its  destruction  as comfirmed  by  the   
pathological  changes  seen  in  the  liver.  This  finding  is  in  
agreement  with  Kurokawa  et al.  (1990).            
 
 
 
 
Concolusions 
 
 
         From the result  obtained,  we  can  conclude  that;  
1-    The toxicity  of  potassium  bromate  is  dose  dependent. In  Sudan                         
the  problem to ban KBrO3 is difficult as  the  technical  equipments 
for  measuring  potassium  bromate  in  small amount is  not 
available in a wide range.   
2-    More  studies  is  needed  for exposure of KBrO3 for a longer time to         
Confirm its carcinogenicity.   
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